SCENARIO 3 — MLO 3.3 — Reаd cаrefully befоre аnswering Questiоns 9 thrоugh 12. A pharmaceutical company is deciding whether to fast-track a new drug through regulatory approval. Four people have significant influence over the decision: the CEO (who controls resource allocation and sets the company agenda), the Chief Medical Officer (a world-renowned researcher whose clinical judgment is trusted across the industry), the Head of Regulatory Affairs (who can withhold sign-off required for any FDA submission), and a senior sales manager (who has worked with most of the key hospital accounts for 20 years and is deeply respected by the field team). QUESTION 9 OF 4: Which power base BEST describes the Chief Medical Officer's influence in this decision?